Friends of Sheba from Canada Hosted Under the Stars Gala
In June, the Friends of Sheba from Canada, an organization dedicated to spreading awareness and raising support for Sheba Medical Center’s compassionate care, cutting-edge research, and comprehensive educational training, hosted the prestigious Under the Stars Gala. Celebrating the Abraham Accords as well as the new era of peace, collaboration, and coexistence they ushered in, the event featured prominent speakers, including Yoel Har-Even, Director of Sheba Global, and His Excellency Abdulla Bin Rashed Al Khalifa, Ambassador of the Kingdom of Bahrain to the U.S. and Canada.
During a live panel discussion, the two discussed the positive impact of the Abraham Accords on international healthcare collaborations.
After signing the Abraham Accords in 2020, which normalized relations between Israel and several other Middle Eastern countries, healthcare collaborations soon began to blossom.
The Bahrain Supreme Council of Health recently chose Sheba Medical Center to lead medical cooperation between the two countries, and agreements were reached with two large Bahraini hospitals: Salmaniya Medical Complex and King Hamad University Hospital. Sheba also signed a memorandum of understanding with health authorities in Abu Dhabi, and is already providing healthcare services to local residents via its virtual hospital, Sheba Beyond.
More Posts
Sheba Medical Center Join General Catalyst’s Health Assurance Ecosystem to Advance Innovative Medical Solutions
General Catalyst is a leading US-based venture capital firm specializing in early-stage and growth investments across various industries, including technology, healthcare, and consumer goods. Known for its strategic approach and deep industry knowledge, General Catalyst not only provides financial support to entrepreneurs but also offers valuable guidance and resources to help them navigate the complex challenges of building and expanding their businesses.
Revolutionizing Diagnostic Medicine: Sheba Partners with Aidoc for Early Intracerebral Hemorrhages Detection
A pioneer in the application of AI in clinical settings, Sheba has played a central role in the development of numerous solutions that are now used across the globe. This includes Aidoc, which was founded at Sheba and now provides advanced AI decision-support tools to many of the world’s leading medical centers.
Sheba and Vidac Pharma Partner to Overcome the Warburg Effect
CAR T-cell therapy is a revolutionary blood cancer treatment that involves extracting and genetically engineering a patient’s T-cells to produce chimeric antigen receptors, or CARs, that facilitate the targeting and elimination of malignant cells.
